Supratentorial Malignant Brain Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-03-20
Clinical Trial Update: Study of Immunotoxin, MR1-1 [Phase 1]
Phase 1 study of the immunotoxin MR1-1 for supratentorial malignant brain tumors has been terminated.